425 related articles for article (PubMed ID: 14624621)
1. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
Gallazzi F; Wang Y; Jia F; Shenoy N; Landon LA; Hannink M; Lever SZ; Lewis MR
Bioconjug Chem; 2003; 14(6):1083-95. PubMed ID: 14624621
[TBL] [Abstract][Full Text] [Related]
2. Radiometal-labeled peptide-PNA conjugates for targeting bcl-2 expression: preparation, characterization, and in vitro mRNA binding.
Lewis MR; Jia F; Gallazzi F; Wang Y; Zhang J; Shenoy N; Lever SZ; Hannink M
Bioconjug Chem; 2002; 13(6):1176-80. PubMed ID: 12440850
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of bcl-2 expression in small lymphocytic lymphoma using 111In-labeled PNA-peptide conjugates.
Jia F; Figueroa SD; Gallazzi F; Balaji BS; Hannink M; Lever SZ; Hoffman TJ; Lewis MR
J Nucl Med; 2008 Mar; 49(3):430-8. PubMed ID: 18287262
[TBL] [Abstract][Full Text] [Related]
4. Comparative biodistributions and dosimetry of [¹⁷⁷Lu]DOTA-anti-bcl-2-PNA-Tyr³-octreotate and [¹⁷⁷Lu]DOTA-Tyr³-octreotate in a mouse model of B-cell lymphoma/leukemia.
Balkin ER; Liu D; Jia F; Ruthengael VC; Shaffer SM; Miller WH; Lewis MR
Nucl Med Biol; 2014 Jan; 41(1):36-42. PubMed ID: 24267052
[TBL] [Abstract][Full Text] [Related]
5. Copper-64-labeled anti-bcl-2 PNA-peptide conjugates selectively localize to bcl-2-positive tumors in mouse models of B-cell lymphoma.
Jia F; Balaji BS; Gallazzi F; Lewis MR
Nucl Med Biol; 2015 Nov; 42(11):809-15. PubMed ID: 26239085
[TBL] [Abstract][Full Text] [Related]
6. Targeted antisense radiotherapy and dose fractionation using a (177)Lu-labeled anti-bcl-2 peptide nucleic acid-peptide conjugate.
Liu D; Balkin ER; Jia F; Ruthengael VC; Smith CJ; Lewis MR
Nucl Med Biol; 2015 Sep; 42(9):704-10. PubMed ID: 26081917
[TBL] [Abstract][Full Text] [Related]
7. Imaging endogenous gene expression in brain cancer in vivo with 111In-peptide nucleic acid antisense radiopharmaceuticals and brain drug-targeting technology.
Suzuki T; Wu D; Schlachetzki F; Li JY; Boado RJ; Pardridge WM
J Nucl Med; 2004 Oct; 45(10):1766-75. PubMed ID: 15471847
[TBL] [Abstract][Full Text] [Related]
8. Microwave-assisted solid-phase synthesis of antisense acpP peptide nucleic acid-peptide conjugates active against colistin- and tigecycline-resistant E. coli and K. pneumoniae.
Hansen AM; Bonke G; Hogendorf WFJ; Björkling F; Nielsen J; Kongstad KT; Zabicka D; Tomczak M; Urbas M; Nielsen PE; Franzyk H
Eur J Med Chem; 2019 Apr; 168():134-145. PubMed ID: 30807888
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel polydiamidopropanoate dendrimer PNA-peptide chimeras for non-invasive magnetic resonance imaging of cancer.
Amirkhanov NV; Wickstrom E
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):423-6. PubMed ID: 16247963
[TBL] [Abstract][Full Text] [Related]
10. Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates.
Koppelhus U; Awasthi SK; Zachar V; Holst HU; Ebbesen P; Nielsen PE
Antisense Nucleic Acid Drug Dev; 2002 Apr; 12(2):51-63. PubMed ID: 12074365
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding.
Mishra R; Su W; Pohmann R; Pfeuffer J; Sauer MG; Ugurbil K; Engelmann J
Bioconjug Chem; 2009 Oct; 20(10):1860-8. PubMed ID: 19788302
[TBL] [Abstract][Full Text] [Related]
12. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates.
Kaihatsu K; Huffman KE; Corey DR
Biochemistry; 2004 Nov; 43(45):14340-7. PubMed ID: 15533038
[TBL] [Abstract][Full Text] [Related]
13. MicroPET imaging of MCF-7 tumors in mice via unr mRNA-targeted peptide nucleic acids.
Sun X; Fang H; Li X; Rossin R; Welch MJ; Taylor JS
Bioconjug Chem; 2005; 16(2):294-305. PubMed ID: 15769082
[TBL] [Abstract][Full Text] [Related]
14. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.
Zhao X; Wang N; Ren X; Zhang J; Wang J; Han J; Jia L; Liu Y; Zhang Z
J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447
[TBL] [Abstract][Full Text] [Related]
15. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
Kilk K; Langel U
Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
[TBL] [Abstract][Full Text] [Related]
16. In vitro transcriptional and translational block of the bcl-2 gene operated by peptide nucleic acid.
Mologni L; Nielsen PE; Gambacorti-Passerini C
Biochem Biophys Res Commun; 1999 Oct; 264(2):537-43. PubMed ID: 10529398
[TBL] [Abstract][Full Text] [Related]
17. Intracellular delivery of antisense peptide nucleic acid by fluorescent mesoporous silica nanoparticles.
Ma X; Devi G; Qu Q; Toh DF; Chen G; Zhao Y
Bioconjug Chem; 2014 Aug; 25(8):1412-20. PubMed ID: 25055196
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake and biological activity of peptide nucleic acids conjugated with peptides with and without cell-penetrating ability.
Turner Y; Wallukat G; Säälik P; Wiesner B; Pritz S; Oehlke J
J Pept Sci; 2010 Jan; 16(1):71-80. PubMed ID: 19943337
[TBL] [Abstract][Full Text] [Related]
19. Inhibiting gene expression with peptide nucleic acid (PNA)--peptide conjugates that target chromosomal DNA.
Hu J; Corey DR
Biochemistry; 2007 Jun; 46(25):7581-9. PubMed ID: 17536840
[TBL] [Abstract][Full Text] [Related]
20. Facile synthesis of peptide nucleic acids and peptide nucleic acid-peptide conjugates on an automated peptide synthesizer.
Joshi R; Jha D; Su W; Engelmann J
J Pept Sci; 2011 Jan; 17(1):8-13. PubMed ID: 20979047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
